Moshe Giladi
Chief Science Officer, NovoCure Ltd.
Companies
- NovoCure LtdChief Science Officer Dec 20, 2023 to Feb 29, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- NovoCure Ltd NVCR69,771 shares2$1.0M at $14.41Feb 27, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 27, 2024Granted 51,124 shares at $16.30 of NovoCure Ltd2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNovoCure Ltd, Chief Science Officer
- 2